Mark G. Olavesen
- Immunology top 10%
- Molecular Biology
- Hematology top 10%
- Genetics
- Physiology
- Co-authors
- B. Paul MorganRobert DanielsAlun DaviesP J LachmannSeppo MeriHerman WaldmannM. SnoekCory Teuscher
- Topics
- Genomic variations and chromosomal abnormalities (3 papers)Heat shock proteins research (3 papers)RNA modifications and cancer (2 papers)
- Cited by
- ImmunologyHematologyNephrology
- Partner nations
- United KingdomNetherlandsUnited States
In The Last Decade
Mark G. Olavesen
15 papers receiving 732 citations
Peers
Comparison fields: 5 of 76
- Immunology 414
- Molecular Biology 275
- Hematology 130
- Genetics 121
- Physiology 109
Countries citing papers authored by Mark G. Olavesen
This map shows the geographic impact of Mark G. Olavesen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark G. Olavesen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark G. Olavesen more than expected).
Fields of papers citing papers by Mark G. Olavesen
This network shows the impact of papers produced by Mark G. Olavesen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark G. Olavesen. The network helps show where Mark G. Olavesen may publish in the future.
Co-authorship network of co-authors of Mark G. Olavesen
This figure shows the co-authorship network connecting the top 25 collaborators of Mark G. Olavesen. A scholar is included among the top collaborators of Mark G. Olavesen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark G. Olavesen. Mark G. Olavesen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 11 | |
| 3 | 30 | |
| 4 | 24 | |
| 5 | 14 | |
| 6 | 30 | |
| 7 | 13 | |
| 8 | 3 | |
| 9 | 24 | |
| 10 | 14 | |
| 11 | 8 | |
| 12 | 13 | |
| 13 | 57 | |
| 14 | 4 | |
| 15 | Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. | 457 |
About Mark G. Olavesen
Mark G. Olavesen is a scholar working on Immunology, Gastroenterology and Genetics, having authored 15 papers that have together received 749 indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (3 papers), Heat shock proteins research (3 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Immunology (414 citations), Hematology (130 citations) and Nephrology (59 citations). Mark G. Olavesen has collaborated with scholars based in United Kingdom, Netherlands and United States. Frequent co-authors include B. Paul Morgan, Robert Daniels, Alun Davies, P J Lachmann, Seppo Meri, Herman Waldmann, M. Snoek, Cory Teuscher, R. Duncan Campbell and Maurice P.H.M. Jansen. Their work appears in journals such as Diabetes, Genome Research and Journal of Investigative Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.